Nebivolol (Bystolic®), a novel, highly cardioselective, third-generation β-blocker that recently received approval by the US FDA for the treatment of hypertension in the USA, is effective in ...

Clinical trials have compared nebivolol at target dosages of 5 and 10 mg once daily with placebo and, in small trials, with carvedilol in the treatment of adults with chronic heart failure.

Discover all the brand names or Trade names of generic drug called Nebivolol. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...